Legal Representation
Attorney
David Ewen
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 24, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 18, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 18, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 20, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 19, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 19, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 5, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research in the field of oncology and cancer treatment; Pharmaceutical research and development; Research and development in the field of oncology and cancer treatment
Additional Information
Design Mark
The mark consists of the wording "RADD PHARMACEUTICALS" in stylized lettering to the left of which is a representation of a helicase consisting of a circular band of smaller shaded ovals, wrapping around a Y-shaped representation of double stranded DNA unwinding into two single strands.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"